Angina, Stable Clinical Trial
— EASEOfficial title:
Effects of Acupuncture on Symptoms of Stable Angina: A Randomized Controlled Trial
NCT number | NCT06311461 |
Other study ID # | 22-001111 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 1, 2024 |
Est. completion date | June 30, 2027 |
The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina. This study addresses the critical need to reduce persistent pain for angina. The investigators long-term goal is symptom management for diverse women and men with angina, targeting additional angina burden borne of social disadvantage Participants will be randomized to a 10-acupuncture session protocol, two treatments per week for five weeks, or an attention control group. Participants will view designated, non-pain related Technology, Entertainment, Design Talks equal to the time spent receiving acupuncture (~7.5-10 hrs.). The investigators will test the efficacy of acupuncture for stable angina/chest pain syndrome to reduce pain and symptoms, improve health-related quality of life, reduce healthcare utilization and and improve patient related health outcomes.
Status | Recruiting |
Enrollment | 112 |
Est. completion date | June 30, 2027 |
Est. primary completion date | December 31, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility | Inclusion Criteria: - Diagnosis of stable angina or chest pain syndrome for at least 1 month (pain, pressure, or discomfort in the chest or other areas of the upper body) - Treated with medical therapy for at least 1 month - Experiencing symptoms at least once per week - Speak and read English - 21 years of age minimum Exclusion Criteria: - Co-morbid conditions of autoimmune dysfunction, or COPD to avoid confounding symptoms - Pregnancy as some acupuncture points included in the protocol are contraindicated in pregnancy - Physical or cognitive limitations that will prevent informed consent or completion of study tasks - Use of steroid or prescription analgesic medications - Concomitant physical therapy, biofeedback, massage, or other acupuncture |
Country | Name | City | State |
---|---|---|---|
United States | UCLA School of Nursing | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of California, Los Angeles | University of Illinois at Chicago |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Now | numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable right now | Baseline to 10 weeks | |
Primary | Worst Pain | numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable | Baseline to 10 weeks | |
Primary | Least Pain | numeric rating scale 0-10, 0=no pain and 10=worst pain imaginable | Baseline to 10 weeks | |
Primary | Acute Coronary Syndrome like symptoms (ACS Symptom Checklist) | Change in Acute coronary syndrome type symptoms. (13 individual symptoms measured dichotomously, 0=no, did not experience, 1=yes, did experience), | Baseline to 10 weeks | |
Primary | Anginal Pain (Seattle Angina Questionnaire-7) | Participants will be asked: Over the past 4 weeks, on average, how many times have you had chest pain, chest tightness, or angina? 6 point scale. HIgher number is better. | Baseline to 10 weeks | |
Primary | Number of Angina Attacks (From American Heart Association Angina Log) | How many times the participant has had angina | Baseline to 10 weeks | |
Primary | Symptom Triggers (From American Heart Association Angina Log) | Participant will be Asked: What triggered the angina attack? | Baseline to 10 weeks | |
Primary | Pain from Angina Attack (From American Heart Association Angina Log) | 4-point scale. 1-little pain to 4-severe pain. | Baseline to 10 weeks | |
Primary | Length of Angina Attack (American Heart Association Angina Log) | In minutes | Baseline to 10 weeks | |
Primary | Self-treatment for Symptoms (From American Heart Association Angina Log) | Participants will be asked to list strategies they used to mitigate pain | Baseline to 10 weeks | |
Secondary | Functional Status Related to Angina (Seattle Angina Questionnaire-7) | Rate physical limitation due to chest pain chest tightness, or angina over the past 4 weeks | Baseline and study completion (10 weeks) | |
Secondary | General Functional Status (PROMIS 29v.2) | Rate difficulty of performing 4 specific activities. 5-point scale 1-5 (low score is worse). Range of scores is 4-20. | Baseline and study completion (10 weeks) | |
Secondary | Quality of Life (Seattle Angina Questionnaire-7) | Question: If you had to spend the rest of your life with your chest pain, chest tightness, or angina the way it is right now, how would you feel about that? (Range 1-5; low score is better) | Baseline and study completion (10 weeks) | |
Secondary | Use of Nitrates and Analgesics (AHA Angina log) | Number of times participants treated their pain using nitrates or analgesics. | Baseline and study completion (10 weeks) | |
Secondary | Patient Reported Outcomes (Patient Reported Outcomes Measurement Information System-29v.2 | Participant's Assessment of their Outcomes - 6 domains. 5-point scale. Range of Scores 29-145. Higher score is better. | Baseline and study completion (10 weeks) | |
Secondary | Healthcare Utilization | Participants report how many healthcare encounters they have had since the last session | Week 2 through Week 10 | |
Secondary | Ischemia on Electrocardiogram (ECG) | Evidence of Ischemia defined as inverted T wave and/or downsloping ST segment depression | Baseline and study completion (10 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Recruiting |
NCT02870764 -
The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris
|
Phase 4 | |
Completed |
NCT04648306 -
Restore EF Observational Study
|
||
Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
Not yet recruiting |
NCT02280850 -
Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
|
Phase 4 | |
Completed |
NCT04785846 -
Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
|
||
Completed |
NCT03759067 -
Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients
|
N/A | |
Not yet recruiting |
NCT03306550 -
Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin
|
N/A | |
Completed |
NCT03193294 -
CORonary MICrovascular Angina (CorMicA)
|
N/A | |
Completed |
NCT04131816 -
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
|
N/A | |
Recruiting |
NCT06075602 -
COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
|
||
Recruiting |
NCT03783351 -
Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)
|
N/A | |
Recruiting |
NCT06464042 -
Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease
|
||
Not yet recruiting |
NCT05857904 -
Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain
|
N/A | |
Recruiting |
NCT01838148 -
Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
|
||
Terminated |
NCT02914834 -
Acupuncture for Individuals With Stable Angina
|
N/A | |
Recruiting |
NCT05825339 -
Absolute Flow for Ischemia With No Obstructive Coronary Arteries
|
||
Completed |
NCT05804500 -
RecoveryPlus Telerehab Platform Pilot Study
|
N/A | |
Completed |
NCT03518645 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds
|
N/A | |
Terminated |
NCT01550614 -
Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease
|
Phase 3 |